DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main Sells 83,033 Shares of The Clorox Company (NYSE:CLX)

DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main cut its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 31.9% in the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund owned 177,464 shares of the company's stock after selling 83,033 shares during the quarter. DZ BANK AG Deutsche Zentral Genossenschafts Bank Frankfurt am Main owned 0.14% of Clorox worth $28,822,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also made changes to their positions in the company. Brooklyn Investment Group increased its position in Clorox by 163.8% during the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company's stock worth $25,000 after buying an additional 95 shares in the last quarter. Redwood Park Advisors LLC purchased a new stake in Clorox during the fourth quarter valued at about $26,000. Millstone Evans Group LLC acquired a new stake in Clorox during the 4th quarter worth approximately $31,000. Asset Planning Inc purchased a new position in shares of Clorox in the 4th quarter valued at $32,000. Finally, GKV Capital Management Co. Inc. purchased a new position in Clorox in the fourth quarter valued at about $32,000. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Clorox Trading Up 2.5%

Shares of Clorox stock traded up $3.32 during trading on Monday, hitting $138.08. The stock had a trading volume of 1,684,427 shares, compared to its average volume of 1,308,779. The stock has a 50 day simple moving average of $142.37 and a 200 day simple moving average of $154.03. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37. The company has a market capitalization of $17.02 billion, a PE ratio of 37.73, a P/E/G ratio of 2.62 and a beta of 0.60.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing the consensus estimate of $1.57 by ($0.12). Clorox had a return on equity of 316.87% and a net margin of 6.38%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the prior year, the business posted $1.71 earnings per share. The business's revenue for the quarter was down 8.0% compared to the same quarter last year. On average, research analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, May 9th. Shareholders of record on Wednesday, April 23rd were paid a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.53%. The ex-dividend date was Wednesday, April 23rd. Clorox's dividend payout ratio (DPR) is presently 87.61%.

Analyst Ratings Changes

CLX has been the subject of several analyst reports. Barclays decreased their target price on shares of Clorox from $134.00 to $129.00 and set an "underweight" rating for the company in a research note on Wednesday, May 7th. DA Davidson lowered their price objective on shares of Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research report on Wednesday, February 5th. Morgan Stanley reduced their price target on shares of Clorox from $165.00 to $150.00 and set an "equal weight" rating for the company in a report on Tuesday, May 6th. Royal Bank of Canada reiterated a "sector perform" rating and set a $150.00 price target on shares of Clorox in a research report on Thursday, January 30th. Finally, JPMorgan Chase & Co. lowered their price objective on shares of Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research note on Tuesday, May 6th. Three analysts have rated the stock with a sell rating, eleven have given a hold rating and one has assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $151.23.

Insider Buying and Selling

In other news, Director Pierre R. Breber acquired 4,000 shares of the firm's stock in a transaction that occurred on Wednesday, May 7th. The stock was acquired at an average cost of $136.57 per share, with a total value of $546,280.00. Following the acquisition, the director now owns 4,000 shares in the company, valued at approximately $546,280. This represents a ∞ increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.57% of the stock is currently owned by corporate insiders.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.